Abstract:Key Teaching Points•This study shows another example of the negative effects associated with using the alleged genotype to determine the presumed phenotype. In this case, the patient and her family were led down a treatment path designed for a channelopathy with which they should not have been diagnosed.•Genetic testing should never be used to make a primary diagnosis of Brugada syndrome (BrS) in isolation, especially when the clinical phenotype of BrS is sorely missing.•While guidelines have provided a major effort towards the standardization of variant interpretation, inter-laboratory differences in the use and implementation of the American College of Medical Genetics criteria exist.•Unfortunately, some genetic testing companies still conflate the mere presence of a specific variant in an early manuscript as evidence for pathogenicity, despite these reports lacking (1) adequate numbers of healthy controls, (2) functional characterization of the variant, or (3) illustration of proper co-segregation with the disease phenotype within a multigenerational pedigree; each of which individually, and more so concomitantly, constitutes more definitive evidence in the interrogation of a potentially pathogenic variant. •This study shows another example of the negative effects associated with using the alleged genotype to determine the presumed phenotype. In this case, the patient and her family were led down a treatment path designed for a channelopathy with which they should not have been diagnosed.•Genetic testing should never be used to make a primary diagnosis of Brugada syndrome (BrS) in isolation, especially when the clinical phenotype of BrS is sorely missing.•While guidelines have provided a major effort towards the standardization of variant interpretation, inter-laboratory differences in the use and implementation of the American College of Medical Genetics criteria exist.•Unfortunately, some genetic testing companies still conflate the mere presence of a specific variant in an early manuscript as evidence for pathogenicity, despite these reports lacking (1) adequate numbers of healthy controls, (2) functional characterization of the variant, or (3) illustration of proper co-segregation with the disease phenotype within a multigenerational pedigree; each of which individually, and more so concomitantly, constitutes more definitive evidence in the interrogation of a potentially pathogenic variant.

Major Causes of Conflicting Interpretations of Variant Pathogenicity in Rare Disease: A Systematic Analysis

Toward Automatic Variant Interpretation: Discordant Genetic Interpretation Across Variant Annotations for ClinVar Pathogenic Variants

Reasons and Resolutions for Inconsistent Variant Interpretation

Discordance between a deep learning model and clinical-grade variant pathogenicity classification in a rare disease cohort

When a "Disease-Causing Mutation" is Not a Pathogenic Variant.

Characterizing the pathogenicity of genetic variants: the consequences of context

Understanding genetic variants in context

Bioinformatics of germline variant discovery for rare disease diagnostics: current approaches and remaining challenges

Searching PubMed for articles relevant to clinical interpretation of rare human genetic variants

ClinVar: improving access to variant interpretations and supporting evidence

Enhancing Variant of Uncertain Significance (VUS) Interpretation in Neurogenetics: Collaborative Experiences from a Tertiary Care Centre

Inconsistencies between prenatal diagnostic and genetic testing laboratories on variant validation of rare monogenic diseases

A comparative medical genomics approach may facilitate the interpretation of rare missense variation

Missing genetic diversity impacts variant prioritisation for rare disorders

Functional categorization of gene regulatory variants that cause Mendelian conditions

Pervasive mislocalization of pathogenic coding variants underlying human disorders

Identifying pathogenic variants in rare pediatric neurological diseases using exome sequencing

Statistical Dissection of the Genetic Determinants of Phenotypic Heterogeneity in Genes with Multiple Associated Rare Diseases

Guidelines for investigating causality of sequence variants in human disease

Clinical and Laboratory Interpretation of Mitochondrial Mrna Variants

Is Variant Pathogenicity in the Eye of the Beholder? A Case of Unexplained Sudden Cardiac Arrest Highlights the Potentially Dangerous Role of Historical Rare Variant Compendia in SCN5A Rare Variant Adjudication